Xiaodong Tan

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

Cell death discovery

OncoTargets and therapy

Cellular & molecular biology letters

Journal of oncology

Shengjing Hospital of China Medical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shengjing Hospital of China Medical University

China

Professor :: First Department of General Surgery

Publications

Yanan Sun, Dongyi Liu, Xiaobo Zhang, Peng Su, Xin Li, Zhongbo Li, Yingwen Gai, Jingying Li, Zhiyong Yang, Yinlu Ding, Jian Zhu, Xiaodong Tan
Regulation of Hippo/YAP axis in colon cancer progression by the deubiquitinase JOSD1. Cell death discovery 10 (1) (2024)
Yanan Sun, Dongyi Liu, Xiaobo Zhang, Peng Su, Xin Li, Zhongbo Li, Yingwen Gai, Jingying Li, Zhiyong Yang, Yinlu Ding, Jian Zhu, Xiaodong Tan
Regulation of Hippo/YAP axis in colon cancer progression by the deubiquitinase JOSD1. Cell death discovery 10 (1) (2024)
Yanan Sun, Dongyi Liu, Xiaobo Zhang, Peng Su, Xin Li, Zhongbo Li, Yingwen Gai, Jingying Li, Zhiyong Yang, Yinlu Ding, Jian Zhu, Xiaodong Tan
Regulation of Hippo/YAP axis in colon cancer progression by the deubiquitinase JOSD1. Cell death discovery 10 (1) (2024)
Peng Liu, Fuqiang Zu, Hui Chen, Xiaoli Yin, Xiaodong Tan
Exosomal DNAJB11 promotes the development of pancreatic cancer by modulating the EGFR/MAPK pathway. Cellular & molecular biology letters 27 (1) (2022)
Junliang Chen, Huaitao Wang, Lei Zhou, Zhihao Liu, Hui Chen, Xiaodong Tan
A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma. Cancer medicine (2022)
Junliang Chen, Huaitao Wang, Lei Zhou, Zhihao Liu, Xiaodong Tan
A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer. Journal of clinical laboratory analysis 36 (5) (2022)
Xiang Fei, Lingming Kong, Chao Shi, Gang Wang, Chenhai Liu, Cheng Wang, Peng Liu, Xiaodong Tan
Identification of Prognosis-Related Molecular Subgroups and Construction of a Prognostic Prediction Model Using Immune-Related Genes in Pancreatic Cancer. Journal of oncology 2022 (2022)
Fuqiang Zu, Peng Liu, Huaitao Wang, Ting Zhu, Jian Sun, Weiwei Sheng, Xiaodong Tan
Integrated analysis identifies a pathway-related competing endogenous RNA network in the progression of pancreatic cancer. BMC cancer 20 (1) (2020)
Lingming Kong, Peng Liu, Mingjun Zheng, Busheng Xue, Keke Liang, Xiaodong Tan
Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer. Epigenomics 12 (6) (2020)
Lingming Kong, Peng Liu, Mingjun Zheng, Zhongpeng Wang, Yang Gao, Keke Liang, Huaitao Wang, Xiaodong Tan
The miR-1224-5p/ELF3 Axis Regulates Malignant Behaviors of Pancreatic Cancer via PI3K/AKT/Notch Signaling Pathways. OncoTargets and therapy 13 (2020)

Xiaodong Tan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xiaodong Tan